Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

tags : Positive    save search

Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
Published: 2022-06-30 (Crawled : 01:00) - biospace.com/
TAK | News | $14.09 0.36% -1.7% | twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 0.0% C: 0.0%

takhzyro children trial positive results
Celldex Therapeutics Presents Positive Interim Data from Barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria at EAACI 2022
Published: 2022-06-30 (Crawled : 23:00) - globenewswire.com
CLDX | $22.69 -15.84% -3.19% | twitter stocktwits trandingview |
Health Technology
| | O: -12.61% H: 2.61% C: -3.65%

urticaria therapeutics positive study
NeuroSense Therapeutics Reports Positive Preliminary Results from Novel Alzheimer's Biomarker Study
Published: 2022-06-30 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | $3.3 -2.37% -8.28% | twitter stocktwits trandingview |
| | O: 31.35% H: 12.31% C: -15.08%

alzheimer's therapeutics positive results tdp-43 biomarkers
9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome
Published: 2022-06-30 (Crawled : 12:20) - biospace.com/
NMTR | $0.2254 -13.57% -4.14% | twitter stocktwits trandingview |
Health Technology
| | O: -14.4% H: 7.09% C: -15.63%

biopharma positive results
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
Published: 2022-06-30 (Crawled : 12:00) - globenewswire.com
TOMDF | $0.0134 | twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 0.75% C: 0.75%

covid-19 trial tollovir positive biomarkers
Lexicon Announces Positive Top-Line Results From Phase 2 Proof-Of-Concept Study Of LX9211 In Painful Diabetic Neuropathy
Published: 2022-06-29 (Crawled : 23:00) - biospace.com/
LXRX | $1.94 4.3% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.93% H: 15.49% C: 5.16%

lx9211 positive results diabetic
Ventyx Biosciences Announces Positive Topline Phase 1 Data for its Peripheral NLRP3 Inhibitor VTX2735
Published: 2022-06-29 (Crawled : 13:20) - biospace.com/
VTYX | $12.69 3.76% 0.0% | twitter stocktwits trandingview |
Manufacturing
| | O: -1.15% H: 0.0% C: -1.08%

vtx2735 for topline positive
Trevi Therapeutics Reports Positive Results from the Ph2b/3 PRISM Trial of Haduvio™ in the Treatment of Prurigo Nodularis
Published: 2022-06-29 (Crawled : 12:20) - biospace.com/
TRVI A | $2.905 3.38% -0.36% | twitter stocktwits trandingview |
Health Technology
| | O: 21.67% H: 12.55% C: -0.81%

treatment trial therapeutics positive results haduvio
Can-Fite Announces Positive Top-Line Results from Piclidenoson Phase III COMFORT™ Study in Moderate to Severe Psoriasis
Published: 2022-06-29 (Crawled : 12:00) - biospace.com/
CANF | $0.8898 -3.28% -1.1% | twitter stocktwits trandingview |
Health Technology
| | O: 20.37% H: 5.66% C: -3.77%

psoriasis positive results piclidenoson
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
ICVX | $6.41 11.87% 5.06% | twitter stocktwits trandingview |
| | O: 1.68% H: 0.0% C: 0.0%

ivx-121 candidate for topline vaccine positive results phase 1
89bio Reports Positive Topline Results from ENTRIGUE Phase 2 Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG)
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
ETNB 3 d | $3.25 0.93% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%

topline trial positive results
Cyclerion Therapeutics Provides Additional Positive CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation
Published: 2022-06-28 (Crawled : 13:00) - ir.cyclerion.com
CYCN | $0.5975 8.87% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 8.39% H: 0.32% C: -7.82%

cy6463 disease therapeutics positive
WESTERN COPPER AND GOLD ANNOUNCES POSITIVE FEASIBILITY ON CASINO
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
WRN | $1.42 5.97% 0.0% | twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 4.52% H: 0.0% C: -8.64%

positive
Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
KZR M | $9.28 12.21% 3.02% | twitter stocktwits trandingview |
Health Technology
| | O: -1.99% H: 2.96% C: -2.36%

treatment sciences for topline lupus life trial positive results
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 15, 2022
Published: 2022-06-27 (Crawled : 21:00) - globenewswire.com
NDAQ S | $155.63 2.03% 0.93% | twitter stocktwits trandingview |
Finance
| | O: 0.17% H: 0.0% C: 0.0%

nasdaq positive
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
Published: 2022-06-27 (Crawled : 13:20) - biospace.com/
ARTL A | $0.3111 -1.8% -7.26% | twitter stocktwits trandingview |
Health Technology
| | O: 1.07% H: 9.17% C: -1.64%

art26 pre-clinical positive results
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
NRSN | $3.3 -2.37% -8.28% | twitter stocktwits trandingview |
| | O: 54.76% H: 26.92% C: -3.85%

als therapeutics positive results biomarkers
Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
AIMD 4 | $0.2895 | twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 0.0% C: 0.0%

covid-19 preclinical positive results
BridgeBio Pharma Announces Positive Phase 1 Data and Phase 2/3 Trial Design for BBP-711, a Potentially Best-In-Class GO Inhibitor for Primary Hyperoxaluria Type 1 (PH1) and Recurrent Kidney Stone Formers
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
BBIO | $9.89 8.92% 2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 2.22% C: 1.3%

bbp-711 pharma for kidney trial positive phase 1 potential
LYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
Published: 2022-06-27 (Crawled : 11:00) - biospace.com/
MRK | $92.42 1.37% -0.45% | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 2.7% C: 1.3%
FNCTF | News | $11.99 | twitter stocktwits trandingview |
Communications
| | O: 0.62% H: 0.0% C: -0.35%

lynparza treatment for chmp positive cancer

USA Holiday (Independence Day) in 2 days

Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
APPN | News 4 | $47.15 -0.44% 4.22% | twitter stocktwits trandingview |
Technology Services

ARQQ | News | $6.2 -1.74% -2.54% | twitter stocktwits trandingview |
Information

CDNA | News | $22.38 4.19% 0.0% | twitter stocktwits trandingview |
Health Technology

FNCTF | News | $11.99 | twitter stocktwits trandingview |
Communications

HLF | News | $21.56 5.43% 0.0% | twitter stocktwits trandingview |
Distribution Services

HYB | News | $9.16 0% | twitter stocktwits trandingview |
Miscellaneous

NVAX | News 4 | $57.11 11.04% 0.91% | twitter stocktwits trandingview |
Health Technology

OKTA | News 4 | $95.96 6.15% -0.61% | twitter stocktwits trandingview |
Technology Services

OSCR | News | $4.57 7.53% 0.0% | twitter stocktwits trandingview |

PEGA | News | $49.44 3.34% 0.0% | twitter stocktwits trandingview |
Technology Services

PM | News 4 | $99.72 0.99% -0.07% | twitter stocktwits trandingview |
Consumer Non-Durables

TDOC | News | $34.83 4.88% -0.4% | twitter stocktwits trandingview |
Health Services

TILE | News | $12.695 1.24% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

UL | News | $46.29 1.0% -0.02% | twitter stocktwits trandingview |
Consumer Non-Durables

UNLYF | News | $45.67 | twitter stocktwits trandingview |
Consumer Non-Durables